A novel strategy for reducing phospholipids-based matrix effect in LC-ESI-MS bioanalysis by means of HybridSPE

Journal of Pharmaceutical and Biomedical Analysis

Volumn 50, Issue 5, 2009, Pages 867-871

  Pucci, Vincenzo ^a,c   Di Palma, Serena ^b   Alfieri, Anna ^c   Bonelli, Fabio ^c   Monteagudo, Edith ^c  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UTRECHT UNIVERSITY   (Netherlands)

^c IRBM   (Italy)

Author keywords

Bioanalysis; LC MS MS; Mass spectrometry; Matrix effects; Phospholipids

Indexed keywords

ACETONITRILE; GLYCEROPHOSPHORYLCHOLINE; LYSOPHOSPHATIDYLCHOLINE; PHOSPHOLIPID; PROTEIN;

ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; CHEMICAL STRUCTURE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETER; MONITORING; NONHUMAN; PRECIPITATION; PRIORITY JOURNAL; RAT;

ACETONITRILES; ANIMALS; CHEMISTRY TECHNIQUES, ANALYTICAL; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, LIQUID; HUMANS; MODELS, CHEMICAL; PHOSPHOLIPIDS; PLASMA; RATS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; TECHNOLOGY, PHARMACEUTICAL;

EID: 70349163904     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.05.037     Document Type: Article

References (19)

1. Shou W.Z., and Naidong W. Rapid Commun. Mass Spectrom. 17 (2003) 589-597
2. Ismaiel O.A., Halquist M.S., Elmamly M.Y., Shalaby A., and Karnes H.T. J. Chromatogr. B 859 (2007) 84-93
3. Dams R., Huestis M.A., Lambert W.E., and Murphy C.M. J. Am. Soc. Mass Spectrom. 14 (2003) 1290-1294
4. Taylor P.J. Clin. Biochem. 38 (2005) 328-334
5. van De Steene J.C., Mortier K.A., and Lambert W.E. J. Chromatogr. A 1123 (2006) 71-81
6. Jemal M., and Xia Y.Q. Curr. Drug Metab. 7 (2006) 491-502
7. Souverain S., Rudaz S., and Veuthey J. J. Chromatogr. A 1058 (2004) 61-66
8. Wang S., Cyronak M., and Yang E. J. Pharm. Biomed. Anal. 43 (2007) 701-707
9. Little J.L., Wempe M.F., and Buchanan C.M. J. Chromatogr. B 833 (2006) 219-230
10. Myher J.J., Kuksis A., and Pind S. Lipids 24 (1989) 408-418
11. Mei H. In: Korfmacher W. (Ed). Using Mass Spectrometry for Drug Metabolism Studies (2005), CRC Press, Boca Raton, FL 103-150
12. Shen J.X., Motyka R.J., Roach J.P., and Hayes R.N. J. Pharm. Biomed. Anal. 37 (2005) 359-367
13. King R., Bonfiglio R., Fernandez-Metzler C., Miller-Stein C., and Olah T. J. Am. Soc. Mass Spectrom. 11 (2000) 942-950
14. Chambers E., Wagrowski-Diehl D.M., Lu Z., and Mazzeo J.R. J. Chromatogr. B 852 (2007) 22-34
15. Marchese A., McHugh C., Kehler J., and Bi H. J. Mass Spectrom. 33 (1998) 1071-1079
16. K.C. Van Horne, P.K. Bennett, Poster AAPS, 2003, available at http://www.tandemlabs.com/capabilities_publications.html.
17. Want E.J., Smith C.A., Qin C., Van Horne K.C., and Siuzdak G. Metabolomics 2 (2006) 145-154
18. P.K. Bennett, M. Meng, V. Čápka, Poster IMSC, 2006, available at http://www.tandemlabs.com/capabilities_publications.html.
19. Wu S.T., Schoener D., and Jemal M. Rapid Commun. Mass Spectrom. 22 (2008) 2873-2881